For patients whose disease is still not well-controlled, studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.

对于病人来说，疾病还没有得到良好的控制，目前正在进行有关第三种药物即静脉前列腺素类依前列醇的研究。

youdao

For patients whose disease is still not well-controlled, studies are underway investigating the addition of a third agent, the intravenous prostanoid epoprostenol.

对于病人来说，疾病还没有得到良好的控制，目前正在进行有关第三种药物即静脉前列腺素类依前列醇的研究。

youdao